Abstract
Tuberculosis (TB) still represents one of the most overshadowing public health issues, particularly in developing countries. The efforts that are currently being made by the scientific community are many and sprout on various fronts, but can be divided in three basic avenues: development of new vaccines for prevention, generation of new and advanced diagnostic tools, and finally improvement of the chemotherapy. An "outside-the-box" approach is hence needed to develop new and improved instruments to fight Mycobacterium tuberculosis, the causative agent of TB. Cutting-edge technologies, such as nanotechnologies, can provide innovative and powerful tools to conquer this ancient infectious disease. Here, some notable examples of how nanotechnologies have entered in infectious diseases field will be presented, discussing how the "white plague," namely the TB, can represent a paradigm of a complex infectious disease whose several aspects must be kept in consideration.
| Original language | English |
|---|---|
| Pages (from-to) | 134-138 |
| Number of pages | 5 |
| Journal | Nanoscience and Nanotechnology Letters |
| Volume | 6 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2014 |
Fingerprint
Keywords
- Diagnosis
- Drug Delivery.
- Mycobacterium Tuberculosis
- Nanoparticles
- Point of Care
- Vaccines
ASJC Scopus subject areas
- Materials Science(all)
Cite this
Role of nanotechnologies against infectious diseases : The paradigm of mycobacterium tuberculosis. perspectives for prevention, diagnosis and treatment. / Morandi, Matteo; Sanguinetti, Maurizio; Delogu, Giovanni.
In: Nanoscience and Nanotechnology Letters, Vol. 6, No. 2, 02.2014, p. 134-138.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Role of nanotechnologies against infectious diseases
T2 - The paradigm of mycobacterium tuberculosis. perspectives for prevention, diagnosis and treatment
AU - Morandi, Matteo
AU - Sanguinetti, Maurizio
AU - Delogu, Giovanni
PY - 2014/2
Y1 - 2014/2
N2 - Tuberculosis (TB) still represents one of the most overshadowing public health issues, particularly in developing countries. The efforts that are currently being made by the scientific community are many and sprout on various fronts, but can be divided in three basic avenues: development of new vaccines for prevention, generation of new and advanced diagnostic tools, and finally improvement of the chemotherapy. An "outside-the-box" approach is hence needed to develop new and improved instruments to fight Mycobacterium tuberculosis, the causative agent of TB. Cutting-edge technologies, such as nanotechnologies, can provide innovative and powerful tools to conquer this ancient infectious disease. Here, some notable examples of how nanotechnologies have entered in infectious diseases field will be presented, discussing how the "white plague," namely the TB, can represent a paradigm of a complex infectious disease whose several aspects must be kept in consideration.
AB - Tuberculosis (TB) still represents one of the most overshadowing public health issues, particularly in developing countries. The efforts that are currently being made by the scientific community are many and sprout on various fronts, but can be divided in three basic avenues: development of new vaccines for prevention, generation of new and advanced diagnostic tools, and finally improvement of the chemotherapy. An "outside-the-box" approach is hence needed to develop new and improved instruments to fight Mycobacterium tuberculosis, the causative agent of TB. Cutting-edge technologies, such as nanotechnologies, can provide innovative and powerful tools to conquer this ancient infectious disease. Here, some notable examples of how nanotechnologies have entered in infectious diseases field will be presented, discussing how the "white plague," namely the TB, can represent a paradigm of a complex infectious disease whose several aspects must be kept in consideration.
KW - Diagnosis
KW - Drug Delivery.
KW - Mycobacterium Tuberculosis
KW - Nanoparticles
KW - Point of Care
KW - Vaccines
UR - http://www.scopus.com/inward/record.url?scp=84894200647&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84894200647&partnerID=8YFLogxK
U2 - 10.1166/nnl.2014.1701
DO - 10.1166/nnl.2014.1701
M3 - Article
AN - SCOPUS:84894200647
VL - 6
SP - 134
EP - 138
JO - Nanoscience and Nanotechnology Letters
JF - Nanoscience and Nanotechnology Letters
SN - 1941-4900
IS - 2
ER -